Bryan Perry

Title: Innovations by Inventor Bryan Perry

Introduction

Bryan Perry is an accomplished inventor based in West Seneca, NY (US). He has made significant contributions to the field of respiratory therapies, holding a total of four patents. His work focuses on innovative methods for treating excess mucus accumulation in mammals.

Latest Patents

One of Bryan Perry's latest patents involves the use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant. This patent outlines methods and devices for administering gaseous inhaled nitric oxide or nitric oxide-releasing compounds to treat excess mucus accumulation. The delivery of gaseous nitric oxide can be performed nasally or orally, ideally coinciding with the mammal's inhalation or based on a synchronous parameter of the respiratory cycle. The patent details varying therapeutic profiles for the delivery of nitric oxide, which depend on the severity of mucus accumulation. Parameters for these profiles include the flow rate of the nitric oxide-containing gas, the duration of administration, the number of breaths for which the gas is administered, and the concentrations of therapeutic nitric oxide delivered to the airways.

Career Highlights

Throughout his career, Bryan Perry has worked with notable companies such as Pulmonox Technologies Corporation and Advanced Inhalation Therapies Ltd. His innovative approaches have positioned him as a key figure in the development of respiratory therapies.

Collaborations

Bryan has collaborated with professionals like Christopher C. Miller and Douglas R. Hole, contributing to advancements in his field.

Conclusion

Bryan Perry's work in developing methods for using inhaled gaseous nitric oxide as a therapeutic agent showcases his dedication to improving respiratory health. His patents reflect a commitment to innovation in medical treatments.